Qi-Fan Yang

Qi-Fan Yang

Auto-generated profile, based on publicly available information

Qi-Fan Yang

Cancer Center, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan

Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
21 January 2019 in International Journal of Cancer
Verified
Journal Article
Closed access
PDF file
YLYang‐Yang Liu
Yang‐Yang Liu
QYQi‐Fan Yang
Qi‐Fan Yang
JYJing‐Song Yang
Jing‐Song Yang
RCRu‐Bo Cao
Ru‐Bo Cao
JLJin‐Yan Liang
Jin‐Yan Liang
LLLi Liu
Li Liu

1 June 2019 in Medicine
Verified
Journal Article
Open access
JLJin-Yan Liang
Jin-Yan Liang
QYQi-Fan Yang
Qi-Fan Yang
YZYu-Lan Zeng
Yu-Lan Zeng
YLYang-Yang Liu
Yang-Yang Liu
YLYu-Ting Liu
Yu-Ting Liu
LLLi Liu
Li Liu
Circulating tumor cells (CTCs) serve as valuable biomarkers. However, MutL homolog 1 (MLH1)-negative CTCs and their clinical significance in lung cancer are nearly unknown. Here, bioinformatic analysis of MLH1 expression and its clinical significance was conducted using the Oncomine, Ualcan, and Kaplan–Meier plotter websites. Size-based isolation and RNA in situ hybridization assays were used to identify CTCs and evaluate MLH1 and mesenchymal marker expression in CTCs. MLH1 was downregulated in lung cancer patients. Patients with lower MLH1 expression levels had worse prognoses. In a cohort of 32 randomly selected patients with lung cancer, the patients with poorer treatment responses had more MLH1-negative CTCs. The total CTCs, MLH1-negative CTCs and mesenchymal markers-expressing CTCs levels were negatively correlated with prognosis in the lung cancer patients. Our data showed the clinical significance of MLH1 expression in lung cancer tissues. The characterization and numeration of CTCs based on the expression of MLH1 and mesenchymal markers may be a convenient approach for predicting treatment response and prognosis in lung cancer.